title: Are we really tackling the "evidence-based medicine issue" in Alzheimer's disease?
authors.affiliation: Department of Neurology and Psychiatry, "Sapienza" University of Rome, Italy. Electronic address: marco.canevelli@gmail.com.
authors.forename: Marco
authors.initials: M
authors.lastname: Canevelli
authors.affiliation: Department of Neurology and Psychiatry, "Sapienza" University of Rome, Italy.
authors.forename: Giuseppe
authors.initials: G
authors.lastname: Bruno
authors.affiliation: Epidemiology Center, National Institute of Health, Rome, Italy.
authors.forename: Nicola
authors.initials: N
authors.lastname: Vanacore
authors.affiliation: Department of Neurology and Psychiatry, "Sapienza" University of Rome, Italy.
authors.forename: Carlo
authors.initials: C
authors.lastname: de Lena
authors.affiliation: INSERM UMR 1027, Université Paul Sabatier - Toulouse III, France; Gérontopôle, Centre Hospitalier Universitaire de Toulouse, France.
authors.forename: Matteo
authors.initials: M
authors.lastname: Cesari
mesh_terms: D000544:Alzheimer Disease / Q000628:therapy*; D019317:Evidence-Based Medicine / Q000592:standards*; D006801:Humans; D016032:Randomized Controlled Trials as Topic
keywords: Alzheimer's disease; Evidence-based medicine; External validity; Randomized controlled trials